CHINA PHARMA HOLDINGS, INC. Deferred Revenue
CHINA PHARMA HOLDINGS, INC. (CPHI) had Deferred Revenue of $172.36 thousand as of 2016-09-30, per its 10-Q filed 2016-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2016-11-14
- 2016-09-30: Deferred Revenue $172.36K.
- 2016-06-30: Deferred Revenue $346.06K.
- 2016-03-31: Deferred Revenue $534.83K.
- 2015-12-31: Deferred Revenue $708.41K.
| Period end | Deferred Revenue |
|---|---|
| 2016-09-30 | $172.36K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $346.06K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $534.83K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $708.41K 10-Q · filed 2016-11-14 |
| 2015-09-30 | $2.43M 10-Q · filed 2015-12-28 |
| 2015-06-30 | $2.54M 10-Q · filed 2015-12-28 |
| 2015-03-31 | $3.18M 10-Q · filed 2015-12-28 |
| 2014-12-31 | $2.52M 10-K · filed 2016-03-30 |
| 2013-12-31 | $0.00 10-K · filed 2015-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |